publication venue for
- Early pathologies in the 3XTG-ad mouse model of Alzheimer's disease 2019
- Neuropsychological assessment of medial frontal functioning in frontotemporal dementia 2016
- Resveratrol protects oxidative stress after ischemic injury by activating Nrf-2 2013
- Differential effects of systems that generate reactive oxygen species on PNS myelin 2008
- Rave trafficking and addiction: A GPCR'S journey 2005
- Modulation of bad phosphorylation in survival and apoptosis in the developing retina 1999
- Nitric oxide synthase inhibitors block nerve growth factor-mediated cholinergic gene expression in PC12 cells 1999
- Common structure and specific features of glutamate receptor channels: Molecular modeling. 1998
- Molecular characterization of a new MBP mutant: The Long Evans shaker rat. 1997
- Ultrastructural study of the central nervous system of the Long Evans shaker rat. 1996
- AN IMMUNOHISTOCHEMICAL ANALYSIS OF CD-44 EXPRESSION IN PRIMARY BRAIN-TUMORS 1994
- CHARACTERIZATION OF A PERIPHERIN-LIKE NEUROFILAMENT PROTEIN IN BULLFROG TADPOLE 1994
- HEAT-SHOCK STRESS PROTEINS IN THE MAMMALIAN BRAIN 1993
- Evidence for purine nucleoside phosphorylase (PNP) release from rat C6 glioma cells. 141:208-221. 2017
- A novel anticonvulsant modulates voltage‐gated sodium channel inactivation and prevents kindling‐induced seizures. 126:651-661. 2013
- Receptor protein tyrosine phosphatase sigma regulates synapse structure, function and plasticity. 122:147-161. 2012
- Oxytocin hyperpolarizes cultured duodenum myenteric intrinsic primary afferent neurons by opening BKCa channels through IP3 pathway. 121:516-525. 2012
- Hypoxia inducible factor (HIF)‐2α is required for the development of the catecholaminergic phenotype of sympathoadrenal cells. 110:622-630. 2009
- Long‐term changes in neurotrophic factor expression in distal nerve stump following denervation and reinnervation with motor or sensory nerve. 105:1244-1252. 2008
- Novel targets for valproic acid: up‐regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. 95:1227-1236. 2005
- Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease. 93:1412-1421. 2005
- The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. 89:581-592. 2004
- Potassium, sodium, calcium and glutamate‐gated channels: pore architecture and ligand action. 88:782-799. 2004
- A new brain‐derived neurotrophic factor transcript and decrease inbrain‐derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. 82:1058-1064. 2002
- cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. 82:1533-1539. 2002
- Inhibitors of nitric oxide synthase attenuate nerve growth factor‐mediated increases in choline acetyltransferase expression in PC12 cells. 81:624-635. 2002
- Proinflammatory cytokines promote glial heme oxygenase‐1 expression and mitochondrial iron deposition: implications for multiple sclerosis. 77:1386-1395. 2001
- Molecular cloning, localization and characterization of a 40‐kDa catecholamine‐regulated protein. 76:1142-1152. 2001
- Role of Acetylcholine Receptors and Dopamine Transporter in Regulation of Extracellular Dopamine in Rat Carotid Body Cultures Grown in Chronic Hypoxia or Nicotine. 70:653-662. 1998
- Sensitization of G Protein‐Coupled Benzodiazepine Receptors in the Striatum of 6‐Hydroxydopamine‐Lesioned Rats. 69:1920-1926. 1997
- Dopaminergic Properties of Cultured Rat Carotid Body Chemoreceptors Grown in Normoxic and Hypoxic Environments. 69:645-654. 1997
- Interaction of NMDA and Dopamine D2L Receptors in Human Neuroblastoma SH‐SY5Y Cells. 66:2390-2393. 1996
- Covalent Affinity Labeling of Brain Catecholamine‐Absorbing Proteins Using a High‐Specific‐Activity Substituted Tetrahydronaphthalene. 65:2783-2789. 1995
- Evidence for D2 Receptor Regulation of Dopamine Release in the Goldfish Retina. 61:2025-2033. 1993
- 3‐[(3‐Cholamidopropyl)dimethylammonio]‐1‐Propane Sulfonate‐Solubilized Binding Sites for 2‐[125I]Iodomelatonin in Chick Brain Retain Sensitivity to Guanine Nucleotides. 56:580-586. 1991
- Galanin‐Like Immunoreactivity Is Unchanged in Alzheimer's Disease and Parkinson's Disease Dementia Cerebral Cortex. 51:1935-1941. 1988
- Interaction of l‐Prolyl‐l‐Leucyl Glycinamide with Dopamine D2 Receptor: Evidence for Modulation of Agonist Affinity States in Bovine Striatal Membranes. 50:960-968. 1988
- Sub cellular Fractionation of the Longitudinal Smooth Muscle/Myenteric Plexus of Dog Ileum: Dissociation of the Distribution of Two Plasma Membrane Marker Enzymes. 49:1124-1132. 1987
- Neurotensin‐Metabolizing Peptidases in Rat Fundus Plasma Membranes. 49:507-512. 1987
- Cerebral Metabolism of 6–[18F]Fluoro‐l‐3,4‐Dihydroxyphenylalanine in the Primate. 48:1077-1082. 1987
- Characterization of High‐Affinity Dopamine D2 Receptors and Modulation of Affinity States by Guanine Nucleotides in Cholate‐Solubilized Bovine Striatal Preparations. 47:1493-1502. 1986
- Somatostatin Binding Sites in Human and Monkey Brain: Localization and Characterization. 46:359-365. 1986
- The Structural Conservation of S100 Protein During Evolution: Analysis by Reactivity with a Monoclonal Antibody. 41:107-112. 1983
- Analysis of Messenger RNA Coding for S100 Protein in the Mammalian Brain. 35:823-828. 1980
- Gamma‐aminobutyric acid determination in human cerebrospinal fluid by mass‐fragmentography. 30:911-913. 1978
- AXONAL TRANSPORT IN NIGRO‐STRIATAL AND NIGRO‐THALAMIC NEURONS: EFFECTS OF MEDIAL FOREBRAIN BUNDLE LESIONS AND 6‐HYDROXYDOPAMINE1. 19:1697-1708. 1972